Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             11 results found
no title author magazine year volume issue page(s) type
1 A phase I–II study of rituximab, ifosfamide, mitoxantrone andetoposide (R-IME) for B cell non-Hodgkin’s lymphoma prior to and after high-dose chemotherapy and autologous stem cell transplantation (HDC-ASCT) Joyce, R.M.

14 S1 p. i21-i27
article
2 Current role and future perspectives for ifosfamide in the treatment of malignant non-Hodgkin’s lymphoma—resultsfrom an expert meeting Sneller, V.

14 S1 p. i1-i3
article
3 Hodgkin’s lymphoma: what is next in salvage treatment? Gisselbrecht, C.

14 S1 p. i37-i38
article
4 Ifosfamide, carboplatin, etoposide (ICE)-based second-line chemotherapy for the management of relapsed and refractory aggressive non-Hodgkin’s lymphoma Zelenetz, A.D.

14 S1 p. i5-i10
article
5 Ifosfamide, epirubicin and etoposide (IEV) in non-Hodgkin’s lymphoma and Hodgkin’s disease: the Italian experience Zinzani, P.L.

14 S1 p. i43-i45
article
6 Ifosfamide salvage treatment before autologous stem cell transplantation in patients with refractory and relapsed Hodgkin’s lymphoma: a GELA experience Gisselbrecht, C.

14 S1 p. i39-i41
article
7 Impact of chemotherapy regimen and hematopoietic growth factor on mobilization and collection of peripheral blood stem cells in cancer patients Nowrousian, M.R.

14 S1 p. i29-i36
article
8 Outpatient-based ifosfamide, carboplatin and etoposide (ICE) chemotherapy in transplant-eligible patients with non-Hodgkin’s lymphoma and Hodgkin’s disease Hertzberg, M.S.

14 S1 p. i11-i16
article
9 Outpatient regimen rituximab plus ifosfamide, carboplatin and etoposide (R-ICE) for relapsed non-Hodgkin’s lymphoma Vose, J.

14 S1 p. i17-i20
article
10 Strategic approach to the management of Hodgkin’s disease incorporating salvage therapy with high-dose ifosfamide, etoposide and epirubicin: a Northern Region Lymphoma Group study (UK) Proctor, S.J.

14 S1 p. i47-i50
article
11 Table of Contents
14 S1 p. ii
article
                             11 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands